- Home
- / Memgen
Memgen
Total Funding
$8.5 M
Memgen Summary
Company Summary
- Overview
- Memgen is a clinical-stage biotechnology company. It develops immunotherapies to help patients with cancer, autoimmune conditions, and infectious diseases.
- Type
- Private
- Status
- Active
- Founded
- 2004
- HQ
- Houston, TX, US | view all locations
- Website
- http://memgenbio.com/
- Cybersecurity rating
Table of Contents
Key People
Mark Cantwell, Chief Scientific Officer, Director
Patricia Bitar, Director
Casey Logan, Director
